You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Revlimid

Showing 51 - 75 of 598
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High-risk Smoldering Multiple Myeloma, Multiple Myeloma Trial in Boston (Daratumumab, Bortezomib, Lenalidomide)

Recruiting
  • High-risk Smoldering Multiple Myeloma
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Oct 18, 2021

Myelodysplastic Syndrome Trial in France, Germany, Spain (Lenalidomide, Placebo)

Active, not recruiting
  • Myelodysplastic Syndrome
  • Strasbourg, Bajo Rin, France
  • +24 more
Nov 22, 2021

Myelodysplastic Syndrome, Multiple Myeloma, Hodgkin Lymphoma Trial (Pembrolizumab, Lenalidomide 20 mg, Lenalidomide 25 mg)

Completed
Has Results
  • Myelodysplastic Syndrome
  • +6 more
  • Pembrolizumab
  • +2 more
  • (no location specified)
Aug 2, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Sacramento (Lenalidomide)

Completed
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Sacramento, California
    University of California Davis
Mar 8, 2022

Multiple Myeloma, Cancer Trial in Chapel Hill, Durham, Columbus (Isatuximab, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Cancer
  • Chapel Hill, North Carolina
  • +2 more
Jun 30, 2022

Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Duarte, California
  • +9 more
Jan 11, 2023

MDS Trial in United States (Lenalidomide, Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • Miami, Florida
  • +5 more
Sep 28, 2022

Mantle Cell Lymphoma Trial in United States (lenalidomide, rituximab)

Active, not recruiting
Has Results
  • Mantle Cell Lymphoma
  • Tampa, Florida
  • +3 more
Mar 26, 2022

Multiple Myeloma Trial in Chicago, Detroit, Poznan (Lenalidomide, Carfilzomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Chicago, Illinois
  • +2 more
Jun 29, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta, Ann Arbor, Saint Louis (Dexamethasone, Ixazomib,

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Atlanta, Georgia
  • +3 more
Jan 6, 2023

Plasmacytoma Trial in United Kingdom (Lenalidomide, Dexamethasone, No further treatment)

Active, not recruiting
  • Plasmacytoma
  • Bath, United Kingdom
  • +12 more
Dec 22, 2022

Chronic Lymphocytic Leukemia Trial in New York (thalidomide, lenalidomide, rituximab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • New York, New York
    Weill Cornell Medical College
Dec 23, 2021

Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Chicago, Rochester, Cleveland (Venetoclax, Umbralisib, Ublituximab)

Terminated
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin Lymphoma
  • Chicago, Illinois
  • +2 more
Aug 19, 2022

Multiple Myeloma Trial run by the NCI (Carfilzomib, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 10, 2021

Multiple Myeloma, Amyloidosis Trial in Toronto (Lenalidomide, Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Amyloidosis
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Nov 26, 2021

Plasma Cell Myeloma Trial in Jacksonville (procedure, biological, drug)

Active, not recruiting
  • Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Mar 25, 2022

Grade 3a Follicular Lymphoma, Recurrent Follicular Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Houston (other,

Completed
  • Grade 3a Follicular Lymphoma
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2023

Lymphoma, Large B-Cell, Diffuse Trial in Saint Louis, Columbus (Brentuximab vedotin, Lenalidomide)

Completed
  • Lymphoma, Large B-Cell, Diffuse
  • Saint Louis, Missouri
  • +1 more
Feb 16, 2022

REVLIMID® Treatment of IPSS Low- or Intermediate-1-risk

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Anyang, Korea, Republic of
  • +12 more
Apr 6, 2021

Solid Organ Malignancies, Adenoidcystic Carcinoma, Neuroendocrine Tumors Trial in Atlanta (Lenalidomide, Everolimus)

Completed
Has Results
  • Solid Organ Malignancies
  • +2 more
  • Atlanta, Georgia
  • +1 more
Nov 19, 2021

Multiple Myeloma Trial in Italy, Switzerland (Nelfinavir, Lenalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Milano, Italy
  • +10 more
Jul 4, 2022

Non Hodgkin's Lymphoma Trial in Sacramento, Santa Rosa (Rituximab, Lenalidomide)

Active, not recruiting
  • Non Hodgkin's Lymphoma
  • Sacramento, California
  • +1 more
Nov 15, 2021

Mantle Cell Lymphoma Trial in New York (Acalabrutinib, Lenalidomide, Rituximab)

Recruiting
  • Mantle Cell Lymphoma
  • New York, New York
    Weill Cornell Medicine
Oct 29, 2021

Smoldering Plasma Cell Myeloma Trial in Houston (procedure, drug, biological)

Recruiting
  • Smoldering Plasma Cell Myeloma
  • Biopsy Specimen Radiography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 12, 2021

Plasma Cell Myeloma Trial in United States (isatuximab SAR650984, lenalidomide, dexamethasone)

Active, not recruiting
  • Plasma Cell Myeloma
  • isatuximab SAR650984
  • +2 more
  • San Francisco, California
  • +4 more
Jun 16, 2022